Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1307

1.

Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients.

Ohya M, Negi S, Sakaguchi T, Koiwa F, Ando R, Komatsu Y, Shinoda T, Inaguma D, Joki N, Yamaka T, Ikeda M, Shigematsu T.

J Clin Endocrinol Metab. 2014 Jun 17:jc20134396. [Epub ahead of print]

PMID:
24937533
[PubMed - as supplied by publisher]
2.

A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.

Prajapati VA, Galani VJ, Shah PR.

Saudi J Kidney Dis Transpl. 2014 May;25(3):530-8.

PMID:
24821148
[PubMed - indexed for MEDLINE]
Free Article
3.

Fibroblast growth factor-23, cardiovascular prognosis, and benefit of Angiotensin-converting enzyme inhibition in stable ischemic heart disease.

Udell JA, Morrow DA, Jarolim P, Sloan S, Hoffman EB, O'Donnell TF, Vora AN, Omland T, Solomon SD, Pfeffer MA, Braunwald E, Sabatine MS.

J Am Coll Cardiol. 2014 Jun 10;63(22):2421-8. doi: 10.1016/j.jacc.2014.03.026. Epub 2014 Apr 9.

PMID:
24727254
[PubMed - in process]
4.

Fragility fractures and osteoporosis in CKD: pathophysiology and diagnostic methods.

Salam SN, Eastell R, Khwaja A.

Am J Kidney Dis. 2014 Jun;63(6):1049-59. doi: 10.1053/j.ajkd.2013.12.016. Epub 2014 Mar 13. Review.

PMID:
24631043
[PubMed - indexed for MEDLINE]
5.

Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids.

Ingulli EG, Mak RH.

Curr Opin Pediatr. 2014 Apr;26(2):187-92. doi: 10.1097/MOP.0000000000000070.

PMID:
24535500
[PubMed - in process]
6.

Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.

Takahashi H, Komaba H, Takahashi Y, Sawada K, Tatsumi R, Kanai G, Suzuki H, Kakuta T, Fukagawa M.

J Clin Endocrinol Metab. 2014 Apr;99(4):E652-8. doi: 10.1210/jc.2013-4050. Epub 2014 Jan 29.

PMID:
24476081
[PubMed - indexed for MEDLINE]
7.

Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.

Sakan H, Nakatani K, Asai O, Imura A, Tanaka T, Yoshimoto S, Iwamoto N, Kurumatani N, Iwano M, Nabeshima Y, Konishi N, Saito Y.

PLoS One. 2014 Jan 23;9(1):e86301. doi: 10.1371/journal.pone.0086301. eCollection 2014.

PMID:
24466013
[PubMed - in process]
Free PMC Article
8.

Cinacalcet for managing secondary hyperparathyroidism in dialysis patients in clinical practice in Belgium: a 16-month observational study (ECHO-B).

Debelle F, Meeus G, Dratwa M, Maes B, Vanholder R, Albert A, Schutyser E, Jadoul M.

Acta Clin Belg. 2013 Jul-Aug;68(4):275-81.

PMID:
24455797
[PubMed - indexed for MEDLINE]
9.

The value of serum FGF-23 as a cardiovascular marker in HD patients.

Sany D, Elsawy AE, Aziz A, Elshahawy Y, Ahmed H, Aref H, El Rahman MA.

Saudi J Kidney Dis Transpl. 2014 Jan;25(1):44-52.

PMID:
24434381
[PubMed - indexed for MEDLINE]
Free Article
10.

Determinants of bone mineral density in patients on haemodialysis or peritoneal dialysis--a cross-sectional, longitudinal study.

Nybo M, Jespersen B, Aarup M, Ejersted C, Hermann AP, Brixen K.

Biochem Med (Zagreb). 2013;23(3):342-50.

PMID:
24266305
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure.

Colussi G, Ganon L, Penco S, De Ferrari ME, Ravera F, Querques M, Primignani P, Holtzman EJ, Dinour D.

Nephrol Dial Transplant. 2014 Mar;29(3):636-43. doi: 10.1093/ndt/gft460. Epub 2013 Nov 13.

PMID:
24235083
[PubMed - in process]
12.

Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.

Tsai WC, Peng YS, Yang JY, Hsu SP, Wu HY, Pai MF, Chang JF, Chen HY.

Blood Purif. 2013;36(2):116-21. doi: 10.1159/000353415. Epub 2013 Nov 5.

PMID:
24217122
[PubMed - indexed for MEDLINE]
13.

rHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients.

Erkmen Uyar M, Toprak SK, Saglam H, Tutal E, Bay M, Ilhan O, Bal Z, Sezer S.

ScientificWorldJournal. 2013 Sep 30;2013:792698. doi: 10.1155/2013/792698. eCollection 2013.

PMID:
24198729
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Calciphylaxis and subtotal parathyroidectomy: a double-edged sword.

Katikaneni M, Lwin L, Villanueva H, Yoo J.

Hemodial Int. 2013 Oct;17 Suppl 1:S33-6. doi: 10.1111/hdi.12087.

PMID:
24134329
[PubMed - indexed for MEDLINE]
15.

Fibroblast growth factor-23 and cardiovascular events in CKD.

Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, Raj DS, Yang W, He J, Lash JP, Go AS, Kusek JW, Feldman H, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

J Am Soc Nephrol. 2014 Feb;25(2):349-60. doi: 10.1681/ASN.2013050465. Epub 2013 Oct 24.

PMID:
24158986
[PubMed - indexed for MEDLINE]
16.

Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.

Fukagawa M, Kido R, Komaba H, Onishi Y, Yamaguchi T, Hasegawa T, Kurita N, Fukuma S, Akizawa T, Fukuhara S.

Am J Kidney Dis. 2014 Jun;63(6):979-87. doi: 10.1053/j.ajkd.2013.08.011. Epub 2013 Oct 8.

PMID:
24119541
[PubMed - indexed for MEDLINE]
17.

Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.

Nakamura M, Tanaka K, Marui Y, Tomikawa S.

Ther Apher Dial. 2013 Oct;17(5):551-6. doi: 10.1111/1744-9987.12018. Epub 2013 Feb 17.

PMID:
24107283
[PubMed - indexed for MEDLINE]
18.

[Importance of selenium homeostasis in chronic and end-stage kidney diseases].

Kiss I.

Orv Hetil. 2013 Oct 13;154(41):1641-7. doi: 10.1556/OH.2013.29733. Review. Hungarian.

PMID:
24095914
[PubMed - indexed for MEDLINE]
Free Article
19.

Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.

Perrin P, Caillard S, Javier RM, Braun L, Heibel F, Borni-Duval C, Muller C, Olagne J, Moulin B.

Am J Transplant. 2013 Oct;13(10):2653-63. doi: 10.1111/ajt.12425. Epub 2013 Aug 26.

PMID:
24034142
[PubMed - indexed for MEDLINE]
20.

Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients.

Naumnik B, Klejna K, Koc-Żórawska E, Myśliwiec M.

Adv Med Sci. 2013;58(2):382-7. doi: 10.2478/ams-2013-0026.

PMID:
23959668
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk